Andrew T. Blair
Profile
Andrew T.
Blair held former positions as Vice President of Clinical Research at Genzyme Corp., Proteon Therapeutics, Inc., and Vice President of Medical Affairs at Affymax, Inc. He also worked as a Principal at the University of Texas Health Center.
Blair received his undergraduate degrees from Rush University and the University of Illinois.
Former positions of Andrew T. Blair
| Companies | Position | End |
|---|---|---|
| AFFYMAX, INC. | Chief Tech/Sci/R&D Officer | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
| University of Texas Health Center | Corporate Officer/Principal | - |
| PROTARA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Andrew T. Blair
| University of Illinois | Undergraduate Degree |
| Rush University | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| AFFYMAX, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Andrew T. Blair
